Diabetes

Insulin icodec, which will be sold under the brand name Awiqli, is shown in a handout photo. Canada is the first country to get the product, which was approved by Health Canada in March for the treatment of adults with Type 1 and Type 2 diabetes. HO/THE CANADIAN PRESS

World’s first weekly insulin injections coming to Canada

Awiqli available June 30 for treatment of adults with Type 1 and Type 2 diabetes

 

(Photo/Flickr)

B.C. residents with early-stage type 1 diabetes needed for drug study

Clinical trials in Vancouver seeking 17 patients for ongoing clinical trials

 

Perry Chow, who has diabetes, stands beside the pickup truck he wasn’t allowed to drive for five weeks while his licence was suspended. (Ella Matte/News Staff)

Mixup ends in suspension of diabetic man’s driver’s licence in Victoria

Delayed mail and letters land driver in car trouble

 

Cole Alexander is a Saanich teenager trying to get his driver’s licence. (Ella Matte/News Staff)

B.C. family cries foul over driving test delay due to diabetes

A processing delay with teen’s medical form makes him unable to book a test

Cole Alexander is a Saanich teenager trying to get his driver’s licence. (Ella Matte/News Staff)
FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. (AP Photo/Darron Cummings, File)

Drug used in diabetes treatment Mounjaro helped dieters shed 60 pounds: study

Drug had to be combined with intensive diet and exercise

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26, 2017. A new study finds that the medicine in the diabetes drug Mounjaro helped people with obesity or who are overweight lose at least a quarter of their body weight. (AP Photo/Darron Cummings, File)
People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared with another medication approved specifically for obesity management, a University of British Columbia study suggests. Diabetes drug Ozempic is shown at a pharmacy in Toronto on Wednesday, April 19, 2023. THE CANADIAN PRESS/Joe O’Connal

Ozempic, similar drugs linked to gastrointestinal conditions: Canadian study

Previous studies have highlighted some risks in patients with diabetes

People using diabetes drugs such as Ozempic for weight loss are at higher risk of pancreatitis, bowel obstruction and stomach paralysis compared with another medication approved specifically for obesity management, a University of British Columbia study suggests. Diabetes drug Ozempic is shown at a pharmacy in Toronto on Wednesday, April 19, 2023. THE CANADIAN PRESS/Joe O’Connal
B.C. PharmaCare is now covering the FreeStyle Libre flash glucose monitor diabetes device. The government announced the coverage Aug. 1. (Unsplash)

B.C. PharmaCare to cover another diabetes device

FreeStyle Libre is an externally worn flash glucose monitor

B.C. PharmaCare is now covering the FreeStyle Libre flash glucose monitor diabetes device. The government announced the coverage Aug. 1. (Unsplash)
FILE - The Eli Lilly & Co. corporate headquarters are seen in Indianapolis on April 26, 2017. Tirzepatide, an drug from the company approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday, April 27, 2023. (AP Photo/Darron Cummings, File)

Powerful new obesity drug poised to upend weight loss care

Industry analysts predict that tirzepatide could become one of the top-selling drugs ever

FILE - The Eli Lilly & Co. corporate headquarters are seen in Indianapolis on April 26, 2017. Tirzepatide, an drug from the company approved to treat type 2 diabetes under the brand name Mounjaro, helped people with the disease who were overweight or had obesity lose up to 16% of their body weight, or more than 34 pounds, over nearly 17 months, the company said on Thursday, April 27, 2023. (AP Photo/Darron Cummings, File)
The Canadian Pharmacists Association says protecting Canadian drug supplies from mass exportation to the U.S. market remains a priority in light of B.C.’s recent move to limit sales of the diabetes drug Ozempic, which has been hyped as a weight-loss treatment. Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz

Rush for diabetes and weight-loss drug Ozempic puts cross-border sales in spotlight

Large-scale American demand for cheaper Canadian drugs threaten country’s supplies

The Canadian Pharmacists Association says protecting Canadian drug supplies from mass exportation to the U.S. market remains a priority in light of B.C.’s recent move to limit sales of the diabetes drug Ozempic, which has been hyped as a weight-loss treatment. Prescription drugs are seen on shelves at a pharmacy in Montreal on March 11, 2021. THE CANADIAN PRESS/Ryan Remiorz
B.C. Health Minister Adrian Dix pauses while responding to questions during a news conference in Vancouver on Monday, November 7, 2022. Dix plans to announce actions on how the government will ensure patients in the province will have secure access to the diabetes and weight loss drug Ozempic. THE CANADIAN PRESS/Darryl Dyck

B.C. to announce plan for access to diabetes drug Ozempic, hyped for weight loss

Almost 10 per cent of prescriptions for the drug in B.C. filled for Americans

B.C. Health Minister Adrian Dix pauses while responding to questions during a news conference in Vancouver on Monday, November 7, 2022. Dix plans to announce actions on how the government will ensure patients in the province will have secure access to the diabetes and weight loss drug Ozempic. THE CANADIAN PRESS/Darryl Dyck
A B.C.-led clinical trial is showing promise for a drug to cure Type 1 diabetes. (Credit: Pixabay/stevepb)

B.C. clinical trial showing promising signs for Type 1 diabetes cure

Two of four completed participants no longer require insulin, study lead says

A B.C.-led clinical trial is showing promise for a drug to cure Type 1 diabetes. (Credit: Pixabay/stevepb)
67 per cent of British Columbians with type two diabetes say their diabetes makes them feel isolated, and 76 per cent feel they are being judged for their diabetes and can’t be honest with their loved ones about their condition. (stevepb/Pixabay) (stevepb/Pixabay)

British Columbians with Type 2 diabetes are struggling with their mental health: survey

Federal diabetes strategy must include emotional support

67 per cent of British Columbians with type two diabetes say their diabetes makes them feel isolated, and 76 per cent feel they are being judged for their diabetes and can’t be honest with their loved ones about their condition. (stevepb/Pixabay) (stevepb/Pixabay)